1)Hara H, Kubo S, Nakajima Y, et al. Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation : Real-world data from the TERMINATOR registry. J Cardiol 2023 : S0914-5087(23)00240-X. doi:10.1016/j.jjcc.2023.09.010. Epub ahead of print. PMID : 37802202.
2)Korsholm K, Berti S, Iriart X, et al. Expert Recommendations on Cardiac Computed Tomography for Planning Transcatheter Left Atrial Appendage Occlusion. JACC Cardiovasc Interv 2020 ; 13 : 277-92.
3)Kar S, Doshi SK, Sadhu A, et al. Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device : Results From the PINNACLE FLX Trial. Circulation 2021 ; 143 : 1754-62.
4)Beigel R, Wunderlich NC, Ho SY, et al. The left atrial appendage : anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging 2014 ; 7 : 1251-65.
5)Porter TR, Mulvagh SL, Abdelmoneim SS, et al. Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography : 2018 American Society of Echocardiography Guidelines Update. J Am Soc Echocardiogr 2018 ; 31 : 241-74.
6)Hemam ME, Kuroki K, Schurmann PA, et al. Left atrial appendage closure with the Watchman device using intracardiac vs transesophageal echocardiography : Procedural and cost considerations. Heart Rhythm 2019 ; 16 : 334-42.
7)Kramer AD, Korsholm K, Jensen JM, et al. Cardiac computed tomography following Watchman FLX implantation : device-related thrombus or device healing? Eur Heart J Cardiovasc Imaging 2023 ; 24 : 250-9.
8)Simard T, Jung RG, Lehenbauer K, et al. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion. J Am Coll Cardiol 2021 ; 78 : 297-313.